Pharma Journalist - Page 9 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Merz, Kvvit Partner to Develop INBRIJA in Greater China

Insilico, HLFM Partner on AI Longevity Models

FDA Grants Fast Track to Elunetirom for Bipolar Depression

Lilly Reports Positive Early Results for VERVE-102

EMA Panel Backs BRAFTOVI for Metastatic Colorectal Cancer

Advancing Respiratory Medicine Following ATS – What Now?

FDA Approves First Hepatitis Delta Treatment in United States

CHMP Supports MAVIRET Approval for Acute Hepatitis C

FDA Approves Datroway for Advanced Triple-Negative Breast Cancer

EMA Fast-Tracks Regeneron Gene Therapy for Rare Hearing Loss